UnitedHealth Group may proceed with its proposal to acquire Change Healthcare, a federal district judge ruled yesterday. The Department of Justice, joined by Minnesota and New York, this year challenged the proposed merger, alleging that the $13 billion transaction would harm competition in commercial health insurance markets and in the market for a vital technology used to process claims and reduce health care costs. AHA had urged DOJ to investigate the proposed acquisition.

“We are disappointed in the court’s decision in the Department of Justice’s lawsuit to block UnitedHealth Group’s acquisition of Change Healthcare,” said AHA General Counsel Melinda Hatton. “We warned that this deal could lead to a massive concentration of sensitive health care data in the hands of a single, powerful owner with an inherent conflict of interest and we remain concerned despite this ruling. We will continue to advocate to protect patients and their health care providers from anticompetitive conduct by commercial health insurance companies and urge federal authorities to remain vigilant.”

Related News Articles

Headline
The Senate Finance Committee today released a discussion draft of legislation to expand the mental health workforce. According to a summary of the provisions,…
Headline
The AHA and American Medical Association today moved to dismiss their challenge to the federal government’s September 2021 interim final rule governing the No…
Headline
The Senate yesterday voted 51-50 to pass the Inflation Reduction Act (H.R. 5376), a roughly $700 billion social spending package that includes health care,…
Headline
The Senate this weekend is expected to take up the Inflation Reduction Act (H.R. 5376), the latest version of the Build Back Better Act, a roughly $700 billion…
Headline
The House Appropriations Committee today voted 32-24 to approve legislation that would provide $242.1 billion in funding for the departments of Labor, Health…
Headline
The Senate Health, Education, Labor & Pensions Committee last night voted 13-9 to advance legislation that would reauthorize Food and Drug Administration…